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ARTICLE
Yin Yang 1 sustains biosynthetic demands during
brain development in a stage-speciﬁc manner
Luis Zurkirchen1, Sandra Varum1, Sonja Giger1, Annika Klug1, Jessica Häusel1, Raphaël Bossart1, Martina Zemke1,
Claudio Cantù2,5, Zeynep Kalender Atak3, Nicola Zamboni4, Konrad Basler2 & Lukas Sommer1
The transcription factor Yin Yang 1 (YY1) plays an important role in human disease. It is often
overexpressed in cancers and mutations can lead to a congenital haploinsufﬁciency syndrome
characterized by craniofacial dysmorphisms and neurological dysfunctions, consistent with
a role in brain development. Here, we show that Yy1 controls murine cerebral cortex
development in a stage-dependent manner. By regulating a wide range of metabolic pathways
and protein translation, Yy1 maintains proliferation and survival of neural progenitor cells
(NPCs) at early stages of brain development. Despite its constitutive expression, however,
the dependence on Yy1 declines over the course of corticogenesis. This is associated with
decreasing importance of processes controlled by Yy1 during development, as reﬂected by
diminished protein synthesis rates at later developmental stages. Thus, our study unravels a
novel role for Yy1 as a stage-dependent regulator of brain development and shows that
biosynthetic demands of NPCs dynamically change throughout development.
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YY1 syndrome is a rare intellectual disability disorder,which is caused by mutations in the human Yin Yang 1(YY1) gene1. Deletions and point mutations of YY1 lead to
a congenital haploinsufﬁciency syndrome characterized mainly by
cognitive impairment, facial dysmorphisms, and developmental
delay. Interestingly, in mice, a subset of embryos lacking one Yy1
allele (Yy1+/− heterozygous) exhibit exencephaly, pseudoven-
tricles, and brain asymmetry2. Although this has not yet
been experimentally addressed, the combined data are consistent
with the hypothesis that Yy1 has a role in mammalian brain
development.
The gene product of Yy1 is a ubiquitously expressed transcrip-
tion factor, which controls transcriptional activation and repression
and has been implicated in enabling enhancer–promoter
interactions3,4. Yy1 exhibits context-dependent roles during the
development and homeostasis of many tissues. It has been shown
to regulate muscle5,6, lung7,8, and cardiac development9 and
intestinal stem cell development and homeostasis10,11. Despite its
ubiquitous expression, Yy1 seems to regulate distinct steps during
the development of these tissues. Depending on the cell type, Yy1
has been associated with various functions, including regulation of
signaling molecules, survival signals, cell cycle regulators or
metabolism5,7,11–13. In the brain, a recent study using short hairpin
RNA (shRNA) against Yy1 suggested a role for Yy1 in promoting
neural progenitor cell (NPC) differentiation at mid-neurogenesis14.
Likewise, Yy1 has been shown to be required for proper differ-
entiation of the oligodendrocytic lineage at postnatal stages
in vivo15. Although it is still unclear how cell type-speciﬁc func-
tions of such an ubiquitous factor are achieved, the central nervous
system and craniofacial structures appear to be especially depen-
dent on the activity of YY1 as evidenced by the phenotype of YY1
loss-of-function in human patients1.
In this report, we genetically ablated Yy1 speciﬁcally in the
developing dorsal cortex of mice. Loss of Yy1 before the onset of
neurogenesis resulted in microcephaly owing to the depletion of
NPCs. We found that ablation of Yy1 induced transient G1/S
phase cell cycle arrest and p53-dependent cell death at embryonic
day 12.5 (E12.5). In contrast, deletion of Yy1 after the onset of
neurogenesis demonstrated a continuously decreasing inﬂuence
on proliferation and cell survival. At the molecular level, loss of
Yy1 at early developmental stages impaired numerous biosyn-
thetic pathways, notably inﬂuencing the expression of metabolic
genes, metabolite abundance, and protein translation rate. Intri-
guingly, at later stages of cortex development, Yy1 inactivation
did not affect metabolic processes anymore and the rate of pro-
tein synthesis was generally reduced in later stage NPCs, revealing
stage-dependent demands for metabolism and protein translation
in cortical development.
Results
Yy1 regulates NPC survival and proliferation. To study the role
of Yy1 in cortex development, we started by determining the
expression pattern of Yy1 at various developmental stages.
Quantitative real-time polymerase chain reaction (QRT-PCR)
analysis and immunostaining demonstrated that Yy1 mRNA and
protein were prominently expressed throughout cortical devel-
opment, with a slight decrease in overall expression levels at
late developmental stages (Supplementary Fig. 1a–c). Notably,
Yy1 protein was detectable in virtually all Sox2+NPCs
and doublecortin (Dcx)+ neuronal cells at all stages analyzed
(Supplementary Fig. 1c). To address the in vivo requirements of
Yy1 in the developing cortex, we conditionally ablated Yy1 by
combining Emx1-Cre mice16 with a transgenic mouse line car-
rying Yy1 alleles ﬂanked by loxP sites (Yy1lx/lx mice17) (Fig. 1a).
In Emx1-Cre Yy1lx/lx mice (hereafter, referred to as Yy1cKO), Yy1
protein expression was lost in single cells as early as embryonic
day 10.5 (E10.5) and was completely absent in the dorsal cortex
from E11.5 onwards (Supplementary Fig. 1d).
At E18.5, the forebrain of Yy1cKO mice was considerably
smaller than that of control mice, which was reﬂected by
signiﬁcantly reduced cortical thickness and number of cells per
radial unit (RU= 100 µm) (Fig. 1b and Supplementary Fig. 1e–g).
Importantly, mesenchymal craniofacial structures known to
inﬂuence forebrain development18,19 and to be malformed in
human YY1 syndrome1 were not affected, consistent with the
known Emx1 expression pattern16. Throughout our analysis,
Emx1-Cre Yy1lx/wt mice appeared morphologically normal and
were viable. This is consistent with previous reports showing lack
of haploinsufﬁciency in mice for a number of congenital diseases,
which indicates differential sensitivity towards gene dosage in
humans vs. rodents20,21. To investigate the cellular mechanisms
underlying the reduction of cortical size in Yy1cKO mice, we
analyzed a potential requirement of Yy1 for proliferation at early
stages of corticogenesis (Fig. 1c, e and Supplementary Fig. 1h–k).
Immunohistochemical analysis revealed reduced numbers of cells
positive for the mitotic marker phosphorylated histone H3
(pHH3) in Yy1cKO brains at E12.5 as compared with the control
(Fig. 1c, e), whereas the ratio of apical vs. basal pHH3+was not
changed (Fig. 1f). Likewise, at E12.5, Yy1cKO cortices displayed
strongly decreased numbers of cells expressing CyclinD1, which is
required for cells to progress through the G1 phase of the cell
cycle (Fig. 1g, i). In contrast, expression of CyclinB1, important
for the transition from G2 to M phase, was not changed upon
conditional Yy1 ablation (Fig. 1j, l).
To conﬁrm the requirement of Yy1 for cell cycle progression,
we isolated NPCs from E11.5 cortices by microdissection to
perform siRNA-mediated knockdown (KD) experiments
(Fig. 1p–r and Supplementary Fig. 1o). CyclinD1 expression
was decreased in siYy1 KD-cells, whereas CyclinB1 expression
remained unchanged (Fig. 1q). Moreover, cell cycle proﬁle
analysis by ﬂow cytometry showed that treatment with siYy1
RNAs retained the cells preferentially in G1, indicating a role of
Yy1 in G1 phase progression (Fig. 1r and Supplementary Fig. 1p).
Apart from proliferation, survival of cortical cells was strongly
affected upon Yy1 inactivation. Indeed, immunostaining for
cleaved Caspase 3 (cCasp3) revealed transiently increased
apoptosis in the forebrain of Yy1cKO mice at E12.5 (Fig. 1m,
o). Similarly, the number of Annexin V+ cells was signiﬁcantly
higher in siYy1-treated cortical cells than in control cells (Fig. 1s),
demonstrating a role of Yy1 in promoting cell survival. In
contrast, Yy1 is apparently not involved in neuronal differentia-
tion as such. Although at E18.5 the numbers of neuronal subtypes
normally found in distinct cortical layers were generally decreased
upon Yy1 inactivation, consistent with the reduced cortical
thickness at this stage, the relative abundance of Dcx+ immature
neurons in comparison with Sox2-expressing NPCs was similar
in Yy1cKO and control forebrains at E12.5 (Supplementary
Fig. 2a–g).
Thus, our data suggest that Yy1 controls proper cortex size by
regulating proliferation and survival of cortical progenitor cells.
Intriguingly, however, when analyzed at E15.5 rather than at
E12.5, the amount of cortex cells expressing pHH3, CyclinD1,
and cleaved Caspase 3, respectively, was not affected anymore in
Yy1cKO embryos (Fig. 1d, e, f, h, i, k, l, n, o), pointing to a speciﬁc
requirement of Yy1 at early stages of development.
Stage-speciﬁc control of NPC behavior by Yy1. To assess
potential stage-speciﬁc roles of Yy1 in cortical development, we
made use of the CreERT2 loxP system, by which activation of
CreERT2 recombinase can be induced at deﬁned stages of
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embryonic development upon tamoxifen (TM) injection of
pregnant females. To this end, Yy1lx/lx mice were mated with
Emx-CreERT2 Yy1lx/wt mice (Emx-CreERT2 from22) to obtain
animals suitable for inducible deletion of Yy1 in the developing
cortex (hereafter referred to as Yy1iKO mice) (Supplementary
Fig. 3a). Non-inducible Emx1-Cre is known to be active in the
developing cortex from around E9.5 onwards16. Accordingly,
TM-induced activation of Emx-CreERT2 in Yy1iKO mice at E9.5
temporarily decreased pHH3+ cells and CyclinD1 expression and
increased apoptosis at E12.5 (Supplementary Fig. 3b–l), in ana-
logy to the phenotype described above for Emx1-Cre-carrying
Yy1cKO mice (Fig. 1). Interestingly, however, when Yy1 deletion
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was induced at E10.5 or later, the effect on forebrain size was
progressively decreasing when compared to Yy1cKO mice, despite
efﬁcient ablation of Yy1 protein expression (Fig. 2a–c and Sup-
plementary Fig. 3m–r). In agreement with this, ablation of Yy1 at
E12.5 affected proliferation and cell death less prominently at
E14.5 and both of these parameters were at control levels at E15.5
(Fig. 2d–k). Moreover, upon TM-induced recombination at
E13.5, the size of Yy1iKO cortices at E18.5 was indistinguishable
from that of control embryos (Fig. 2b, c), and neither cortical cell
proliferation nor apoptosis were signiﬁcantly altered at E15.5 in
these Yy1iKO embryos as compared with the control (Fig. 2l–q).
Thus, despite constitutive expression of Yy1 at later stages
of cortical development (Supplementary Fig. 1c), NPC pro-
liferation and survival are becoming less dependent on Yy1 as
the embryonic brain develops, revealing a stage-dependent role
of Yy1.
With advancing cortical development, the relative number of
intermediate progenitor cells compared to apical NPCs
increases23. To assess whether the phenotype seen in Yy1 mutant
embryos can be attributed to different progenitor cell types, we
performed immunohistochemistry for Pax6 and Tbr2 to
distinguish apical NPCs (Pax6+), intermediate NPCs (Tbr2+),
and apical NPCs transitioning to intermediate NPCs (Pax6+
Tbr2+). At E12.5 and E15.5, both the number of Pax6+ and
Tbr2+ cells per RU were decreased in Yy1cKO embryos
(Supplementary Fig. 4a, b, c, e, f). The relative abundance of
these NPC subtypes, however, were not altered (Supplementary
Fig. 4d, g). Consistent with our previous results, TM-induced
ablation of Yy1 at E12.5 showed a milder phenotype where only
the number of Pax6+ cells per RU at E14.5 was signiﬁcantly
decreased (Supplementary Fig 4h–o). Further, deletion of Yy1 at
E13.5 did neither affect the absolute nor relative number of Pax6,
Tbr2, and Pax6+ Tbr2+ cells (Supplementary Fig. 4p–s).
Together, our data suggest that loss of Yy1 exerts a stage-
speciﬁc effect on cell proliferation and survival in the developing
brain, which cannot just be attributed to different sensitivities of
distinct NPC subpopulations.
Yy1 promotes NPC survival through downregulation of p53.
Yy1 has been shown to inhibit activation of the tumor-suppressor
p53, a well-established regulator of cell cycle progression and
apoptosis24–26. To address whether Yy1 might regulate p53 also
in the developing CNS, we investigated p53 expression in the
forebrain of control and Yy1cKO mice at E12.5. Consistent with
the reported posttranscriptional regulation of p53 by Yy124,25,
p53 protein but not p53 mRNA levels were upregulated upon loss
of Yy1 (Fig. 3a, b). To address a potential involvement of p53 in
Yy1-dependent neural progenitor control, we then crossed
Yy1cKO mice with mice carrying alleles of Trp53 ﬂanked by loxP
sites27 (Fig. 3c). The resulting Yy1 Trp53 double knockout
(Yy1Trp53dKO) mice displayed a cortex with a size intermediate
to control and Yy1cKO cortices at E18.5, indicating that loss of
p53 could partially rescue the Yy1cKO phenotype (Fig. 3d, e). Of
note, immunostaining for cleaved Caspase 3 demonstrated that
the increased cell death observed upon Yy1 inactivation (Fig. 1m,
o) was fully rescued in the absence of p53 (Fig. 3f). In contrast,
loss of p53 did not rescue the proliferation phenotype seen in
Yy1cKO mice, as shown by quantiﬁcation of pHH3 and CyclinD1
expression (Fig. 3g–k).
To substantiate these data, we inactivated p53 signaling in
Yy1cKO mice by administration of the pharmacological inhibitor
Piﬁthrin-α (PFTα) (Supplementary Fig. 5a)28,29. Again, this
approach counteracted cell death induced by conditional Yy1
deletion, albeit not as efﬁciently as genetic p53 inactivation
(Supplementary Fig. 5b). However, the proliferation defect in the
developing forebrain of Yy1cKO mice was still present in PFTα-
treated animals (Supplementary Fig. 5c–g). Thus, regulation of
cortical progenitor survival by Yy1 appears to be largely mediated
by the activity of p53, whereas the control of proliferation by Yy1
is p53-independent.
Yy1 regulates metabolic pathways and protein translation. To
identify further factors potentially mediating Yy1 activity in the
developing forebrain, we evaluated the global gene expression
patterns of control vs. Yy1cKO cortices at E11.5 using RNA-
sequencing (RNA-seq) (Fig. 4a). We identiﬁed 1087 and 467
annotated mRNAs that were downregulated and upregulated,
respectively, in Yy1cKO cells (|log2 fold change| > 0.32, p < 0.05,
FDR < 0.01). To ﬁnd which pathways were speciﬁcally enriched,
we performed gene ontology (GO) analysis and assembled a GO
perturbation network, where GO terms, which share > 50% of the
genes, are connected (Fig. 4b). GO terms enriched upon deletion
of Yy1 revealed alterations in various metabolic pathways, such as
fatty-acid oxidation, nucleic-acid metabolism, and biosynthetic
processes (Fig. 4b, Supplementary Fig. 6 and Supplementary Data
1). Furthermore, mitochondria were identiﬁed as organelles pri-
marily associated with Yy1-dependent changes in gene expres-
sion, in agreement with previous studies on muscle development
and intestinal stem cell homeostasis5,11.
To validate these ﬁndings, we performed qRT-PCR analysis of
selected genes and conﬁrmed that a plethora of factors involved
in metabolic pathways including glycolysis, TCA cycle, lipid
metabolism, and mitochondrial biogenesis were downregulated in
the Yy1cKO forebrain (Fig. 4c, d). Moreover, the expression of
several genes implicated in nucleotide metabolism, ribosome and
tRNA synthesis, and mRNA to protein translation was altered
upon Yy1 inactivation (Fig. 4e). Of note, genes associated with
metabolism and translation, were not rescued by pharmacological
inhibition of p53 signaling in Yy1cKO cortical cells at E12.5
(Supplementary Fig. 7a–c), indicating that Yy1-mediated regula-
tion of these genes is p53 independent in the developing cortex.
Fig. 1 Yy1 maintains proliferation and cell survival at early stages of cortex development. a Genotype of Yy1cKO mice with conditional ablation of Yy1 in the
dorsal cortex. b Deletion of Yy1 leads to decreased cortex (ctx) size at E18.5. c–f Loss of Yy1 decreases the number of pHH3+ cells at E12.5 (c, e). At E15.5,
the number of mitotic cells is comparable to control embryos (d, e). The ratio of apical vs. basal pHH3+ cells does not change upon knockout of Yy1
(f). The number of pHH3+ cells is normalized to 600 μm ventricular zone length (E12.5 and E15.5) and normalized to cortical thickness (E15.5). g–i The
percentage of CyclinD1+ cells decreases upon ablation of Yy1 at E12.5 (g, i), but not at E15.5 (h, i). j–l The percentage of CyclinB1+ cells is not affected in
Yy1cKO embryos. m–o Immunohistochemistry for cleaved Caspase 3 (cCasp3) shows that the number of apoptotic cells transiently increases at E12.5 in
Yy1cKO embryos. Radial unit (RU)= 100 µm. p Experimental outline for knockdown experiments. q Efﬁcient knockdown of Yy1 in isolated E11.5 cortical
progenitor cells decreases CyclinD1 protein levels without affecting CyclinB1 protein levels. r Cell cycle analysis by ﬂow cytometry reveals that knockdown
of Yy1 increases the number of cells in G1 cell cycle phase. s Flow cytometric analysis of the apoptotic marker Annexin V. Knockdown of Yy1 in isolated
E11.5 cortical progenitor cells increases the number of Annexin V+ cells. Nuclei are counterstained with DAPI. Scale bars represent 1 mm (b), 100 μm
(m, n), 50 μm (c, d), 20 μm (g, h, j, k). Comparisons were performed using the two-tailed unpaired Student’s t test. Data are the mean ± standard deviation.
*p < 0.05. ns= not signiﬁcant
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We next analyzed the direct target genes of Yy1 by
interrogating genome-wide occupancy of Yy1 using chromatin
immunoprecipitation followed by sequencing (ChIP-seq) of
cortical cells isolated from E12.5 wild-type embryos (Fig. 5a).
The highest scoring motif corresponded to a known Yy1
consensus binding site containing the core sequence ATGGC
(Fig. 5b)6,11,30. Consistent with previous reports6,11,30, Yy1-
binding events predominantly took place within close proximity
of the transcriptional start site (TSS) of promoter regions (Fig. 5c,
d). Visualizing GO terms enriched for the genes with Yy1-binding
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Fig. 2 Ablation of Yy1 after E12.5 does not inﬂuence cortical development. a Genotype of mice and experimental strategy used to induce ablation of Yy1 at
different developmental stages. b Later stage tamoxifen-induced ablation of Yy1 ameliorates the decrease in cortex size compared with Yy1cKO cortices
(Fig. 1b). c Measurement of cortical length (L) and width (W) as indicated in b. For representative picture of E18.5 Yy1cKO cortex, see Fig. 1b. *p < 0.05.
d Experimental strategy to ablate Yy1 at E12.5 in Yy1iKO embryos (for Fig. 2e–k). e–h Immunostaining and quantiﬁcation for pHH3+ cells at E14.5 (e, g) and
E15.5 (f, g) in E12.5-ablated Yy1iKO embryos. h depicts the ratio of apical vs. basal pHH3+ cells. The number of pHH3+ cells is normalized to 600 μm
ventricular zone length. i–k Ablation of Yy1 at E12.5 elicits cleavage of Caspase 3 (cCasp3) at E14.5 (i, k) but not at E15.5 (j, k). Note that red signals visible
at E15.5 are blood cells. l Experimental strategy to ablate Yy1 at E13.5 in Yy1iKO embryos (for Fig. 2m–q). m–o The total number and ratio of apical vs. basal
pHH3+ cells remains unchanged upon late ablation of Yy1 at E13.5. The number of pHH3+ cells is normalized to 600 μm ventricular zone length. p, q Ablation
of Yy1 at E13.5 only induces cell death in a minority of cells (indicated by arrows, remaining red signals are blood cells). Nuclei are counterstained with DAPI.
Scale bars represent 1 mm (b), 50 µm (e, f, i, j, m, p). Comparisons were performed using ANOVA (Tukey’s multiple comparisons test) (c) and two-tailed
unpaired Student’s t test (g, h, k, n, o, q). Data are the mean ± standard deviation. ns= not signiﬁcant
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motifs in a functionally grouped network demonstrated an
association of Yy1-target genes with metabolism and mitochon-
drial functions as well as with RNA processing, ribosome
biogenesis, and protein translation (Fig. 5e–g, Supplementary
Fig. 8 and Supplementary Data 2). Thus, Yy1 directly controls
expression of numerous gene sets implicated in metabolic and
translational processes.
To functionally test whether the impaired expression of nuclear
encoded mitochondrial genes affects mitochondrial bioenergetics,
we assessed mitochondrial function by measuring the oxygen
consumption rate (OCR) of control and Yy1cKO cells directly
isolated from E12.5 cortices. Real-time measurements of OCR
demonstrated that Yy1 inactivation led to impaired basal
respiration, ATP-linked OCR, and maximal respiration capacities
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genes. Each node represents an enriched GO term (adjusted p value (Corrected with Bonferroni step down procedure) < 0.05). Nodes are interconnected
when the gene overlap is > 50%, based on the kappa score. BP, biological process; MF, molecular function; CC, cellular component. A fully labeled version
of the network is given in Supplementary Fig. 6. c–e qRT-PCR validation for differentially regulated genes comparing control vs Yy1cKO cortical tissue at
E12.5 conﬁrms RNA-seq results. Comparisons were performed using the two-tailed unpaired Student’s t test. Data are the mean ± standard deviation
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-09823-5 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:2192 | https://doi.org/10.1038/s41467-019-09823-5 | www.nature.com/naturecommunications 7
of cortical cells (Fig. 6a, b). These data could not simply be
explained by reduced amounts of mitochondria, as the ratio of
mitochondrial over nuclear DNA (Mit1 and CytB vs intergenic
region) was not altered (Fig. 6c and Supplementary Fig 9a).
Likewise, we excluded that apoptosis contributed to this
phenotype since the number of living cells (7AAD-negative) just
before OCR measurement was not altered in control vs. Yy1cKO
cells (Supplementary Fig 9b, c). To obtain a global overview of
metabolic changes induced by loss of Yy1, we analyzed mass
spectrometry-based metabolic proﬁles of control and siYy1 KD
cortical cells derived from E11.5 embryos. Quantitative examina-
tion of the untargeted metabolomics data showed downregulation
of various metabolic processes including glucose, lipid, amino
acid, and nucleotide metabolism upon Yy1 KD (Fig. 6d and
Supplementary Data 3).
Apart from general metabolic processes, the analysis of our
RNA-seq and ChIP-seq data indicated an involvement of Yy1 in
protein translation. To functionally validate these ﬁndings, we
quantiﬁed global protein synthesis in cortical cells with either
undisturbed or reduced Yy1 levels by measuring incorporation of
O-propargyl-puromycin (OP-puro) into nascent proteins31. In
cells isolated from E11.5 cortices and treated with siYy1 RNA, the
relative protein synthesis rate was highly reduced as compared
with control cells (Fig. 6e, f). Likewise, cells directly isolated
from the dorsal cortex of Yy1cKO embryos at E12.5
displayed signiﬁcantly lower translation rates than measured
in control cortical cells (Fig. 6i, j). To elucidate whether
differences in protein translation might depend on the cell cycle
stage, we performed ﬂow cytometric analysis of OP-puro
incorporation intensity in combination with propidium
a b
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iodide-based measurements of DNA content in siYy1 and
Yy1cKO cells and their respective control cell populations
(Supplementary Fig. 9d). These experiments demonstrated that
proper translation was dependent on Yy1 both in G0/G1 cells
(DNA content= 2c), which comprise NPCs in G1 phase of the
cell cycle and postmitotic neurons potentially present in the cell
preparations, as well as in cycling progenitor cells in S/G2/M
phase (DNA content > 2c) (Fig. 6g, h, k, l).
Stage-dependent requirements for biosynthesis in NPCs. Our
study shows that Yy1 controls a broad spectrum of metabolic
pathways together with global protein synthesis at early stages of
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Fig. 6 Yy1 controls cortical metabolism and protein translation rate. a, b Oxygen consumption rate (OCR) measurement of isolated cortical cells at E12.5
using a Seahorse Extracellular Flux Analyzer reveals impaired mitochondrial bioenergetics upon ablation of Yy1. Injection of electron transport chain
inhibitors are indicated after measurement 3 (oligomycin, ATP synthase inhibitor), 6 (FCCP, mitochondrial uncoupler) and 9 (Antimycin A/rotenone,
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cortical development. The stage-dependent phenotype observed
in Yy1cKO and Yy1iKO embryos (Figs. 1 and 2) raises the
question of whether Yy1 functions might change during the
course of cortical development. To address this we performed
ChIP-seq of wild-type cortical cells at E15.5 (Fig. 7a). Similar to
what we observed at E12.5 (Fig. 5), ChIP-seq for Yy1 at
E15.5 showed that a Yy1-binding element was the most sig-
niﬁcantly enriched motif and that most ChIP-seq peaks were
found in proximity to the TSS of the target genes (Fig. 7b–e).
Surprisingly, binding events which were detected at least once in
both ChIP-seq replicas for E12.5 and E15.5, overlapped to a large
extent between the two developmental stages (Fig. 7f, Supple-
mentary Fig. 9e, f), indicating that Yy1 exhibits a similar binding
pattern at these stages.
Next, we performed RNA-seq analysis of FACS-isolated
Prominin1+ radial glia (RG) cells of Yy1iKO vs control embryos
at E15.5 upon late ablation of Yy1 (Fig. 7g). A total of 1080 genes
were downregulated (660 genes) or upregulated (420 genes) upon
induced knockout of Yy1 (|log2 fold change| > 0.32, p < 0.05, FDR
< 0.05). We then compared changes in gene expression of direct
Yy1 targets at early and late stages. Although some genes with
signiﬁcantly changed expression (p < 0.05, FDR < 0.05) at E11.5
were not changed at E15.5, the majority of genes were similarly
deregulated at both early and late stages (Fig. 7h). Likewise, when
considering both indirect and direct Yy1 targets, the majority of
Yy1-dependent gene products localizing to mitochondria or
involved in metabolism and protein translation were similarly
deregulated at E11.5 and E15.5 (Supplementary Fig. 10a–e).
Accordingly, metabolic processes and lipid metabolism were
enriched among GO terms for downregulated genes in Yy1iKO
embryos at E15.5 (Supplementary Fig. 10f), comparable to the
situation at E11.5 (Fig. 4b). In agreement with the observation
that Yy1 seems to regulate similar genes throughout cortical
development, computational prediction of transcription factor
binding by i-cisTarget32 to ﬁnd Yy1 co-factors revealed that both
at E12.5 and E15.5, the highest enriched motifs were from E2f
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Fig. 7 Yy1 controls a similar gene set throughout cortex development. a Genome-wide binding of Yy1 to DNA regions was analyzed by chromatin
immunoprecipitation followed by deep sequencing (ChIP-seq) of cortex cells derived at E15.5. Statistical analysis of the enriched regions identiﬁed 246 binding
events at E15.5 (FDR < 0.001), present in at least 1 of 2 replicas. b Homer motif discovery revealed the known Yy1-binding motif as the highest scoring motif
(p < 1*e-50). c–e Read cluster proﬁle and distribution of binding sites to different genomic locations at E15.5. Yy1 binds preferentially to the promoter region of
the transcription start site (TSS) of genes. f Analysis of overlap between E12.5 and E15.5 ChIP-seq data. g RNA-seq comparing E15.5 Yy1iKO vs control (each
n= 3 embryos) radial glia cells from the dorsal cortex which were isolated by microdissection and subsequent Prominin1-based (CD133-FITC) FACS. A total of
1080 genes were downregulated (660 genes) or upregulated (420 genes) upon induced knockout of Yy1 (|log2 fold change| > 0.32, p < 0.05, FDR < 0.05).
h RNA-seq expression of genes at E11.5 and E15.5, which are bound by at E12.5 and E15.5, upon knockout of Yy1. *p < 0.05
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and Ets transcription factor family members (Supplementary
Fig. 11a, b). Of note, both E2f and Ets family members have
previously emerged as important metabolic regulators33–37.
However, although many genes of metabolic and biosynthetic
pathways seemed to be affected by Yy1 at both developmental
stages, a small but signiﬁcant fraction of such genes were
differentially regulated at E11.5 but not at E15.5. These included
Ndufc1, Ndufb4, Ndufb5 (subunits of the electron transport
chain), Ppargc1α (negative regulator of glycolysis, promotes
mitochondrial gene expression), Napepld, Cpt1c (lipid metabo-
lism), Eif1b, Rps13, Rpl5, and Akt1s1 (protein translation and
ribosome biogenesis) (Fig. 7h and Supplementary Fig. 10a–e).
Thus, it is possible that this latter group of genes contributes to
the stage-dependent phenotype observed upon ablation of Yy1. In
addition, some genes involved in cell cycle progression were
upregulated speciﬁcally at late stages. However, based on our
ChIP-seq analysis, all but two of these genes were not bound and
only indirectly regulated by Yy1, pointing to compensatory
mechanisms active in E15.5 Yy1iKO NPCs. Moreover, the two
bound genes, Cdk5rap2 and Cdc45, were regulated in the same
direction at both developmental stages. In summary, our data
suggest that the gene regulatory network dependent on Yy1 does
not change overtly along development, raising the question of
whether later stage cortical cells can cope better with the changes
in gene expression induced by Yy1 inactivation.
To functionally address this point, we assessed whether loss of
Yy1 after the onset of neurogenesis inﬂuences mitochondrial
bioenergetics. Intriguingly, basal respiration, ATP-linked OCR,
and maximal respiration capacity at E15.5 were not impaired
upon late Yy1 inactivation (Fig. 8a–c), unlike at E12.5 after early
Yy1 deletion (Fig. 6a, b). Likewise, global protein synthesis rates
were only mildly affected at E15.5, especially when taking into
account proliferating progenitor cells in S/G2/M phase (Fig. 8d–g).
Importantly, global protein synthesis rates of Prom1+ RG cells
of Yy1iKO and control cells were indistinguishable (Fig. 8h, i).
Thus, consistent with the decreasing disturbance of proliferation
and survival observed when Yy1 was ablated at later develop-
mental stages (Fig. 2), mitochondrial bioenergetics and protein
translation were not affected upon Yy1 deletion after the onset of
neurogenesis.
Our data are compatible with the hypothesis that the
dependency of cortical cells on Yy1 is decreasing at later stages
of development, because the main processes regulated by Yy1
might have lost relative importance over time. To address this
hypothesis, we measured overall protein synthesis rates at E10.5,
E12.5 and E15.5 in wild-type embryos. Levels of OP-puro
incorporation were highly reduced in E15.5 cortical cells as
compared with E10.5 and E12.5 cells (Fig. 8j, k and Supplemen-
tary Fig. 12a, b). Translation was also signiﬁcantly lower in late
than in early-stage cortical cells, when assessing OP-puro
incorporation in G0/G1 and cycling S/G2/M cells (Fig. 8l, m
and Supplementary Fig. 12c, d). Finally, the signiﬁcant decrease
in protein translation rate was also apparent when comparing
Prom1+ RG cells at E15.5 vs E12.5 (Fig. 8n, o). Thus, the stage-
dependent phenotype in survival and proliferation of NPCs seen
upon Yy1 inactivation appears to reﬂect stage-dependent
requirements for biosynthetic processes.
Discussion
Regulation of NPC proliferation and survival is essential to ensure
correct brain development. Aberrations in cell cycle progression
and survival of NPCs lead to decreased numbers of NPCs and lie
at the heart of many neurodevelopmental disorders38–41. In this
study, we report a previously unappreciated role for the tran-
scription factor Yy1 in the regulation of brain size. We show that
Yy1 is crucial during early cortical development to sustain NPC
proliferation and survival, in contrast to developmental stages
after the ﬁrst waves of neurogenesis when the activity of
Yy1 seems to be dispensable for cortex development. By using a
combination of genome-wide DNA-binding site identiﬁcation,
transcriptomics, metabolomics, and analysis of protein transla-
tion rates we demonstrate that Yy1 is a key factor safeguarding
biosynthetic demands speciﬁc for early-stage NPCs. Our study
not only reveals that Yy1 controls the expression of metabolic
genes, metabolite abundance and mitochondrial bioenergetics
during corticogenesis, but also shows that Yy1 is functionally
involved in the transcriptional regulation of global protein
synthesis. Possibly, aberrations in these processes may contribute
to the neurodevelopmental defects in humans with heterozygous
YY1 loss-of-function mutations1, although this needs to be
addressed in future studies.
Conditional ablation of Yy1 at early stages of cortical devel-
opment resulted in microcephaly owing to decreased cell pro-
liferation and increased cell death. Emx1-Cre- and Emx1-
CreERT2-dependent recombination leads to ablation of the
ﬂoxed gene in NPCs as well as neurons16,22. However, the
observed phenotype appears to be owing to a requirement for Yy1
in NPCs rather than secondary to defects in neurons, given the
very low number of neurons present at stages displaying the most
prominent phenotype and, vice versa, the absence of a pro-
liferation phenotype at later stages, when many neurons are
present. Moreover, neuronal differentiation as such was not
affected by the loss of Yy1. In addition, siRNA-mediated
knockdown experiments in isolated NPCs recapitulated the
Yy1cKO phenotype, suggesting a cell-autonomous effect speciﬁ-
cally in NPCs.
Increased apoptosis observed upon ablation of Yy1 was
accompanied by accumulation of p53 protein, a tumor-sup-
pressor, which integrates various stress signals and activates
downstream effectors to promote the appropriate cellular
response: either damage repair and cell survival or induction of
apoptosis in irreparable cases42,43. Apoptosis can be induced by
p53-dependent or -independent processes44. By using both
genetic ablation and pharmacological inhibition of p53, we show
that apoptosis induced by the loss of Yy1 is dependent on p53
and contributes to the microcephaly phenotype. Yy1 has been
implicated in the direct regulation of p53 and the phenotype
upon loss of Yy1 in thymocytes can be completely rescued by
p53 deﬁciency26. In contrast, inhibition of p53 in Yy1cKO
embryos neither ameliorated the proliferation phenotype, nor
rescued expression of Yy1-dependent metabolic genes. Thus,
apart from p53-mediated cell death, loss of Yy1 in the cortex
induces a p53-independent stress response that is associated
with impaired proliferation of NPCs. Surprisingly, a recent
study using shRNA-mediated knockdown of Yy1 suggested that
Yy1 limits NPC expansion and promotes differentiation via
repression of Sox2 at E14.514. However, our approach to
genetically delete Yy1 did neither reveal alterations of Sox2
protein expression nor regulation of Sox2 mRNA levels and did
not increase proliferation. Although the reasons for these con-
tradicting ﬁndings remain unclear, it could be explained by the
efﬁciency in reducing Yy1 levels using shRNA compared with
genetic deletion.
Similar to our ﬁndings in the embryonic brain, Yy1 exerts a
pro-proliferative role in many types of cancer45,46, in lung epi-
thelial cells7 and during cardiac development9. Despite the
decreased number of CyclinD1-expressing cells and decrease in
CyclinD1 mRNA expression in the Yy1cKO cortex, we did not
detect direct binding of Yy1 to the promoters of cell cycle pro-
gression genes by ChIP-Seq. This suggests that Yy1 does not
directly regulate the cell cycle machinery of NPCs, but rather
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inﬂuences other cellular pathways important for proper pro-
liferation of early NPCs. Indeed, our molecular analysis demon-
strates that Yy1 is a key transcription factor controlling the
expression of genes involved in central metabolic pathways, such
as glycolysis, TCA cycle, lipid metabolism, nucleotide synthesis,
and subunits of the electron transport chain. In addition, we
observed decreased mitochondrial function in absence of Yy1,
which can further inﬂuence the abundance of precursor mole-
cules for biosynthesis47,48. Yy1 has previously been associated
with the regulation of metabolic functions, thereby supporting the
development and homeostasis of muscle cells and intestinal stem
cells5,10,11. Going beyond these previous reports, our RNA-seq
and ChIP-seq data sets revealed a very broad implication of Yy1
in various metabolic pathways and also identiﬁed several genes
involved in ribosome biogenesis, tRNA synthesis, and protein
translation to be direct targets of Yy1. Although binding of Yy1 to
genes of the protein translation machinery has been observed
before1,6,11,30, this ﬁnding has not been explored further. We now
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demonstrate that Yy1 regulates the expression of these genes and
thereby functionally controls global protein synthesis rates.
Historically viewed as mere housekeeping functions, metabo-
lism and protein translation have arisen as key players coordi-
nating stem cell behavior. Metabolic processes have recently
emerged as crucial factors controlling tissue development and
homeostasis, in particular, of the nervous system49–53. During
cortex development, NPCs have been shown to rely on high
glycolytic rates in order to proliferate50 and to modulate their
mitochondrial morphology upon differentiation51. In addition,
upregulation of electron transport chain components and of
oxidative phosphorylation is critical for fast proliferating inter-
mediate progenitor cells during adult neurogenesis53. Although
little is known about the importance of protein synthesis during
brain development, adult hematopoietic54, hair follicle,55 and
neural stem cells56 have been demonstrated to synthesize less
protein compared with their direct, cycling progeny. Fast pro-
liferating cells therefore seem to depend on increased protein
translation rates, possibly to satisfy their enormous demand of
resources for biomass production. Deregulation in both meta-
bolism and protein translation are known to interfere with cell
proliferation and survival. Cell cycle progression has been shown
to be dependent on the metabolic and nutritional status of a
cell57,58 and impaired mitochondrial bioenergetics alone are
capable of inducing G1/S cell cycle arrest in Drosophila59. Fur-
thermore, ribosome biogenesis stress and increased levels of the
ribosomal protein L5 (Rpl5) could contribute to the accumulation
of p53 protein in Yy1cKO cortices, similar to observations made
in other systems60,61. Thus, the concurrent attenuation of several
metabolic pathways as well as decreased protein translation is
likely too harsh to cope with for fast proliferating NPCs and
results in the upregulation of stress sensors, proliferation defects
and p53-dependent cell death observed in Yy1cKO embryos.
Despite its constitutive expression in NPCs and neurons, our
results show that Yy1 becomes less important over the course of
embryonic neurogenesis. Our data indicate that, overall, Yy1
binds to and regulates similar target genes throughout cortex
development. In agreement, reconstruction of the Yy1 gene reg-
ulatory network revealed that E2F and ETS family members were
the co-factors with the highest enrichment score at both devel-
opmental stages. However, a small subset of genes were Yy1-
dependent at early stages but not altered upon late ablation of
Yy1. Some genes of this group have already been implicated in
processes contributing to the Yy1-dependent phenotype, includ-
ing oxidative phosphorylation (Ndufc162, Ndufb462, Ndufb562),
mitochondrial biogenesis (Ppargc1a63,64), ribosome subunit and
activator of p53 (Rpl561) and inhibition of protein translation
(Akt1s165). Judged by their function, other genes could poten-
tially also inﬂuence cell behavior by modulating lipid metabolism
(Napepld) and protein translation (Eif1b, Rps13). Therefore, it is
conceivable that rescued expression of these genes in late-stage
Yy1iKO cortices may contribute to the ameliorated metabolic
phenotype observed. Surprisingly, many cell cycle progression
genes, although not directly bound by Yy1, were upregulated
speciﬁcally upon late ablation of Yy1. This further emphasizes
stage-speciﬁc transcriptional responses to Yy1 inactivation that
potentially inﬂuence the susceptibility of NPCs toward loss of Yy1
at different developmental stages.
In the complex and highly dynamic environment of brain
development, several cellular processes affect corticogenesis in a
stage-dependent manner. Cell cycle length of NPCs generally
decreases as the embryo develops66–68. As a result of their fast
proliferative nature and their substantial biosynthetic demand,
early NPCs are thought to be especially vulnerable to cellular
stress. For example, genome integrity is vital for NPCs to give rise
to healthy daughter cells, but the susceptibility of NPCs to
genomic stress appears to alter during the course of development.
Interference with genome integrity by ablation of the DNA
replication factor TopBP1 resulted in more pronounced neuro-
developmental defects when induced in early, compared with late
NPCs, despite causing comparable degrees of DNA damage at
both developmental stages69,70. Furthermore, mRNA expression
proﬁling of RNA-binding proteins identiﬁed many genes to be
differentially regulated with progressive cortex development.
Consistent with the high protein-synthesis rate of early NPCs, the
expression of a majority of genes involved in RNA binding,
protein translation, and ribosomal proteins is higher at early
stages of corticogenesis71. Conceivably, this reﬂects the high
biosynthetic demand of fast proliferating, early progenitor cells in
order to synthesize proteins and precursor molecules for biomass
production. In analogy to the temporal difference in vulnerability
to genotoxic stress, our study indicates that early NPCs are par-
ticularly susceptible to metabolic and protein synthesis stress. The
shorter cell cycle might render early NPCs less ﬂexible and
increase their dependency on rapid accumulation of building
blocks. Our ﬁndings thus show that temporal control of basic
cellular processes is critical for brain development. In sum, Yy1
plays a central role in cortex development by inﬂuencing stage-
dependent progenitor cell behavior through transcriptional reg-
ulation of metabolism and protein synthesis.
Fig. 8 Stage-dependent requirements for biosynthesis in NPCs. a Efﬁcient reduction of Yy1 mRNA at E15.5 upon tamoxifen-induced (TM) ablation at E12.5.
b, c Oxygen consumption rate (OCR) measurement of isolated cortical cells at E15.5 using a Seahorse Extracellular Flux Analyzer reveals that mitochondrial
bioenergetics are not altered upon ablation of Yy1 at E12.5. Injection of electron transport chain inhibitors are indicated after measurement 3 (oligomycin, ATP
synthase inhibitor), 6 (FCCP, mitochondrial uncoupler), and 9 (Antimycin A/rotenone, complex III & I inhibitors). Parameters derived from b are indicated in
c: basal respiration, ATP-linked OCR and maximum respiration capacity. Data represented relative to ﬁrst basal respiration measurement of controls and as
mean of n= 9 (control), n= 7 (Yy1iKO), error bars indicate standard error of the mean. d–g Protein translation rate is only mildly affected in Yy1iKO cells at E15.5
upon recombination at E12.5. OP-puro (OPP) intensity histogram of representative E15.5 control and Yy1iKO cells pulsed with OPP for 30min and OPP negative
control (d). Quantiﬁcation of mean ﬂuorescent OPP intensity (e). OPP incorporation in cortical cells in G0G1 (DNA content= 2c) and S/G2/M (DNA content >
2c) phases of the cell cycle (f, g). DNA content was determined using propidium iodide. Note that the protein translation rate of cycling progenitor cells is not
signiﬁcantly altered between control and Yy1iKO embryos. h, i TM-induced ablation of Yy1 at E12.5 does not alter OPP incorporation in Prominin1+ RG cells at
E15.5. j–o Reduced protein translation rate of E15.5 vs E12.5 and E10.5 wild-type cortical cells. OP-puro (OPP) intensity histogram of representative E10.5, E12.5,
and E15.5 cells pulsed with OPP for 30min and OPP-negative control (j). Quantiﬁcation of mean ﬂuorescent OPP intensity (k). OPP incorporation in cortical
cells in G0G1 (DNA content= 2c) and S/G2/M (DNA content > 2c) phases of the cell cycle (l, m). DNA content was determined using propidium iodide. The
reduction of OPP incorporation is also apparent in Prominin1+ RG cells of E15.5 vs E12.5 (n, o). Comparisons were performed using the two-tailed unpaired
Student’s t test. Data are the mean ± standard deviation (a, e, g, i, k, m, o) and ± standard error of the mean (b, c). ns= not signiﬁcant. p Schematic drawing
summarizing the results. The transcription factor Yy1 binds and regulates genes involved in metabolism and protein synthesis. Functional biosynthesis sustains
proliferation and survival of NPCs and eventually leads to correct brain development. Despite constitutive expression of Yy1, cortical NPCs exhibit a stage-
dependent susceptibility to loss of Yy1, which coincides with decreased protein translation rates at later developmental stages
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Methods
Animal models. All animal experiments were conducted in accordance with Swiss
guidelines and approved by the Veterinary Ofﬁce of the Canton of Zurich, Swit-
zerland. Previously described Yy1lx/lx mice17 were crossed to Emx1-Cre16 or Emx1-
CreERT2 mice22 to ablate Yy1 function in the developing cortex (Emx1-Cre Yy1lx/lx,
Emx1-CreERT2 Yy1lx/lx). The following genotypes were used as control animals:
Emx1-Cre Yy1lx/wt, Emx1-Cre Yy1wt/wt, Yy1lx/lx, and Emx1-CreERT2 Yy1lx/wt,
Emx1-Cre ERT2 Yy1wt/wt. To study the function of p53 in the context of Yy1
ablation, previously described Trp53lx/lx mice27 were crossed to Emx1-Cre Yy1lx/lx
mice (Emx1-Cre Yy1lx/lx Trp53 lx/lx). Emx1-Cre Yy1lx/wt Trp53lx/lx served as control
animals. All genotypes were present at Mendelian ratios and control animals
showed no overt phenotype. Wild-type NMRI or Swiss mice (Janvier, France) were
used for ChIP-seq, knockdown experiments, to determine mRNA levels and pro-
tein translation rates at different developmental stages. To generate embryos of a
certain developmental stage, mice were mated overnight and the next morning was
deﬁned as E0.5. Timed ablation of Yy1 in Emx1-CreERT2 Yy1lx/lx mice was induced
by intraperitoneal (i.p.) injection of TM (200 mg/kg body weight, Sigma) into
pregnant females at indicated stages. Pharmacological inhibition of p53 was
achieved by i.p. injection of pregnant females with 2.2 mg/kg body weight PFTα29
(Enzo Life Sciences) twice per day from E10.5–E12.5.
Cell culture and siRNA transfection. NPCs from dorsal E11.5 cortex (NMRI
mice) were isolated by microdissection of the dorsal cortex in Hank's Balanced Salt
Solution (HBSS) (14170, Gibco) and digestion in HBSS (14170, Gibco) containing
0.35 mg/ml collagenase type 3 (M3D14157, Worthington) and 0.04% Trypsin
(7001719, Life Technologies). The digestion mix was inactivated using soybean
trypsin inhibitor (Sigma). Cells were grown on plates (Corning) coated with poly-L-
lysine (Cultrex) and ﬁbronectin (Sigma) in Dulbecco's Modiﬁed Eagle Medium
(DMEM)/F12+Glutamax medium, supplemented with B-27, N2 (all from Gibco),
20 ng/ml basic ﬁbroblast growth factor (bFGF), and 20 ng/ml EGF (both Pepro-
tech) (cortex medium). For RNA interference of Yy1, cells were transfected with
control siRNA (Medium GC Duplex #2, Invitrogen) or siRNAs against Yy1 (Stealth
RNAi, Invitrogen) (Supplementary Table 1) using JetPRIME transfection reagent
(Polyplus). After 48 h of siRNA treatment, cells were harvested using Trypsin
(Gibco) and soybean trypsin inhibitor (Sigma), washed with phosphate-buffered
saline (PBS) (Gibco) and processed for further experiments.
Immunohistochemistry. Embryo heads or E18.5 brains were dissected, washed in
HBSS (Gibco) and ﬁxed overnight in 4 % paraformaldehyde at 4 °C, followed by
dehydration in ethanol and parafﬁn embedding. Sagittal 5-μm parafﬁn sections were
deparafﬁnized, high-pressure antigen retrieval in citrate buffer (pH 6) was performed,
and sections were subsequently stained following standard protocols (washes: PBS or
PBS-TritonX 0.2% (PBS-T); blocking solution: 1% bovine serum albumin (BSA) in
PBS-T). The following primary antibodies were used (diluted in blocking solution):
anti-cleaved caspase 3 (rabbit Cell signaling 9661, 1:300), anti-Ctip2 (rat Abcam
ab18465, 1:200), anti-CyclinB1 (rabbit Santa Cruz sc-752, 1:200), anti-CyclinD1
(mouse Santa Cruz sc-450, 1:50), anti-Dcx (guinea pig Millipore ab2253, 1:300), anti-
p53 (rabbit Santa Cruz sc-6243, 1:50; mouse Cell Signaling, 1:300), anti-Pax6 (mouse
DSHB, 1:50 and rabbit Covance PRB-278P, 1:200), anti-phospho Histone 3 (mouse
PH3 Cell Signaling 9706, 1:300), anti-Reelin (mouse Novus Biological NB600-1081,
1:100), anti-Sox2 (rabbit Chemicon AB5603, 1:100 and mouse R&D MAB2018), anti-
Tbr1 (rabbit Abcam ab31940, 1:200), anti-Tbr2 (rabbit Chemicon AB9618, 1:200),
anti-Yy1 (rabbit sc1703 and mouse sc-7341, both Santa Cruz, 1:100).
Secondary isotype-speciﬁc Alexa488-, Alexa546-, and Alexa647-conjugated
antibodies against mouse were from Invitrogen, secondary biotin anti-rabbit,
steptavidin-, Dylight488-, and DyLight549- conjugated antibodies against other
species were purchased from Jackson ImmunoResearch. Secondary antibodies were
diluted 1:500 in blocking solution and incubated for 1 h at RT. Nuclei were
counterstained with 4′,6-diamidino-2-phenylindole (DAPI, Sigma, 1:2000).
Immunoblotting. Cells or cortex tissue were harvested and lysed in radio-
immunoprecipitation buffer (RIPA) buffer (89900, Thermo Scientiﬁc) containing Halt
Phosphatase and Protease Inhibitor Cocktail (78420, 87786, Thermo Scientiﬁc).
Cortex tissues were homogenized and both, cells, and tissue samples were sonicated in
RIPA buffer. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
was carried out on 4–20% Mini-PROTEAN TGX Gels (456–1094, Bio Rad). The
following primary antibodies (4 °C, O/N, in Odyssey blocking buffer (927–40000, LI-
COR Biosciences)) were used: anti-β-actin (mouse Sigma a5316, 1:10000), anti-
CyclinB1 (rabbit Santa Cruz sc-752, 1:500), anti-CyclinD1 (mouse Santa Cruz sc-450,
1:500), anti-Histone H3 (mouse Cell Signaling, 1:1000), anti-Yy1 (rabbit Santa Cruz
sc1703, 1:500). Blots were stained with isotype-speciﬁc secondary antibodies in
Odyssey blocking buffer for 1 h at room temperature. Blots were scanned and
quantiﬁed with an Odyssey imaging system (LI-COR Biosciences).
Flow cytometry. For assessment of cell death, cells were harvested, washed, and
stained with Annexin V-Cy5 according to the manufacturer’s instructions (BD
Bioscience). For cell cycle analysis, cells were pulsed with EdU (10 μM) for 1 h,
harvested and ﬁxed with 4 % paraformaldehyde. Staining for EdU incorporation
was carried out as indicated by the manufacturer’s instructions (Click-It EdU Flow
Cytometry kit, Thermo Scientiﬁc) and the DNA content was visualized with
propidium iodide. For all ﬂow cytometry experiments, 10,000–50,000 cells were
recorded. All samples were analyzed on a BD FACS Canto II ﬂow cytometer.
FlowJo v7.6.5. was used to process the obtained data.
Quantitative real-time PCR and RNA-sequencing. Dorsal cortex tissue was
dissected and total RNA was isolated with the RNAeasy kit (Qiagen) and RNase-
Free DNase Set (79254, Qiagen) following the manufacturer’s instructions. For
quantitative real-time PCR, RNA was reverse transcribed with the Maxima First
Strand cDNA Synthesis kit (Fermentas, K1641). Quantitative real-time PCR was
carried out using LightCycler® SYBR Green I master mix (Roche, 4887352001) and
was run on a LightCycler® 480 System (Roche). Each experiment was performed in
a minimum of biological and technical triplicates. Obtained data were analyzed by
the ΔCt method and normalized to the expression levels of β-actin for comparing
control and Yy1cKO samples or normalized to the average expression of four
housekeeping genes (β-actin, Mrps6, Tbp, Ywazh) for comparison of different
embryonic stages. Primers used are listed in Supplementary Table 2.
For RNA-sequencing at E11.5, total RNA was isolated of control (n= 3, from
two different litters) and Yy1cKO (n= 3, from two different litters) dorsal cortex
tissue. Sequencing was performed at the Functional Genomics Center Zurich,
Switzerland, using the Illumina HiSeq 2000 platform. The heatmap in Fig. 4a shows
differentially expressed genes with |log2 fold change| > 0.3, p < 0.05, FDR < 0.01.
GO networks were constructed with ClueGO (Version 2.3.2) and Cytoscape
(Version 3.4.0). Clusters with less than 3 nodes were omitted.
For RNA-sequencing at E15.5, cells of control (n= 3) and Yy1iKO (n= 3) dorsal
cortex were isolated, stained for Prominin1 (rat CD133-FITC 1:100, 11-1331,
eBioscience) in HBSS (Gibco) supplemented with 5% FBS for 30min at 4 °C. Cells
were washed with HBSS+ 5% FBS and Prominin1-positive cells were sorted directly
in cold RLT lysis buffer (Qiagen)+ 1% 2-mercaptoethanol. Unstained cells and
isotype-speciﬁc IgG-FITC labeled cells served as negative control for gating. Isolated
RNA was sequenced at the iGE3 Genomics Platform (Geneva, Switzerland) using the
Illumina 4000 platform. RNA-seq data sets are deposited at the European Nucleotide
Archive (ENA) (accession number PRJEB21545 and PRJEB30271).
For the determination of mitochondrial versus genomic DNA content, E12.5
dorsal cortex tissue was dissected and total DNA was isolated with the QiaAmp
DNA kit (Qiagen) following the manufacturer’s instructions. Relative copy
numbers of mitochondrial DNA was determined by quantitative real-time PCR for
mitochondrial and genomic genes (Primers: Supplementary Table 3).
ChIP-sequencing. ChIP material was prepared as previously described72. In brief,
chromatin from dissected dorsal cortex tissue of E12.5 and E15.5 NMRI mice was
prepared and immunoprecipitated according to the manufacturer’s instructions
(Magna A/G ChIP Kit, Millipore). Crosslinked protein–DNA complexes of ~
300–700 bp size were immunoprecipitated using 5 μg of rabbit anti-Yy1 antibody
(sc1703, Santa Cruz) or 5 μg of rabbit IgG antibody (Santa Cruz). After recovery of
the DNA fragments, binding sites were determined by sequencing at the iGE3
Genomics Platform, Geneva, Switzerland, using the Illumina HISeq4000 platform.
Data analysis–peak calling. All sequenced reads were mapped using Bowtie 2
(http://bowtie-bio.sourceforge.net/bowtie2/index.shtml) onto the UCSC mm10
reference mouse genome. The command “ﬁndPeaks” from the HOMER tool
package (http://homer.salk.edu/homer/) was used to identify enriched regions in
the Yy1 immunoprecipitation experiments using the “-style= factor” option
(routinely used for transcription factors with the aim of identifying the precise
location of DNA-protein contact). Input samples were used as enrichment-
normalization control. Peak calling parameters were adjusted as following: L= 2
(ﬁltering based on local signal), F= 2 (fold change in target experiment over input
control). The annotation of peaks’ position (i.e., the association of individual peaks
to nearby annotated genes or genomic loci) was obtained by the all-in-one program
called “annotatePeaks.pl”. Finally, the HOMER program “makeUCSCﬁle” was used
to produce bedGraph formatted ﬁles that can be uploaded as custom tracks and
visualized in the UCSC genome browser (http://genome.ucsc.edu). GO networks
were constructed with ClueGO (Version 2.3.2) and Cytoscape (Version 3.4.0).
Clusters with less than three nodes were omitted. Computational prediction of co-
factors was performed by i-cisTarget32. ChIP-Seq data sets are deposited at the
European Nucleotide Archive (ENA) (accession number PRJEB21635).
Metabolomics. Isolated NPCs from E11.5 cortices were transfected with siCtrl or
siYy1 (n= 9, each). After 48 h, cells were harvested and washed twice with 75mM
ammonium carbonate, ph 7.4, and snap frozen in liquid nitrogen. Metabolites were
extracted two times with cold acetonitrile-methanol-water (40:40:20 ratio, − 20 °C).
Extracted metabolites were analyzed by ﬂow injection–time of ﬂight mass spectro-
metry on an Agilent 6550 QTOF instrument operated in the negative mode as
previously described73. Detectable ions were putatively annotated by matching
measured mass-to-charge ratios with theoretical masses of compounds listed in the
human metabolome database v3.074 using a tolerance of 0.001 amu. Pathway deﬁ-
nition of differentially abundant metabolites was performed with the Small Molecule
Pathway Database75. P values were calculated by two-tailed, heteroscedastic t test and
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were adjusted for FDR according to the Benjamini–Hochberg procedure. All calcu-
lations were done in Matlab (The Mathworks, Natick, MA).
Oxygen consumption measurement. Cells from dorsal E12.5 or E15.5 cortex were
isolated and equal numbers of living cells (determined by Trypan Blue exclusion
assay) were seeded into Seahorse XFp or XFe24 cell plates (Seahorse Bioscience). Cells
were incubated for 3 h at 37 °C and 5% CO2 in cortex medium to allow attachment to
the poly(L-lysine) (PLL)/ﬁbronectin-coated plates. To prepare the cells for OCR
measurement, cells were incubated for 1 h at 37 °C with athmospheric CO2 levels in
non-buffered XF Base DMEM minimal medium supplemented with 0.5mM sodium
pyruvate, 5.5mM glucose, and 2mM glutamine (Seahorse medium). Cell viability prior
to measurement was ensured by staining for 7AAD (BD Bioscience) in an inde-
pendent experiment. OCR was measured on Seahorse XFp or XFe24 extracellular ﬂux
analyzers in Seahorse medium. Relative OCR was assessed upon the injection of 1 μM
oligomycin, 1 µM FCCP and 0.5 μM antimycin A/rotenone (all from Seahorse
bioscience) and normalized to protein content (bicinchoninic acid assay) and the ﬁrst
OCR measurement of control cells. For each condition, at least six embryos from at
least two different litters were measured (n ≥ 6).
Measurement of protein translation rate. Cells were directly isolated from dorsal
E12.5 or E15.5 cortex and equal numbers of cells were seeded into PLL/ﬁbronectin-
coated 96-well plates. Cells were incubated for 2 h at 37 °C in cortex medium to
allow attachment to the plates. Alternatively, cells isolated from E11.5 cortex were
treated with siRNA for 48 h as described above. For measurement of protein
synthesis rates, cells were pulsed with OPP (20 μM, Thermo Scientiﬁc and Jena
Bioscience) for 30 min, harvested and ﬁxed with 4 % paraformaldehyde. Staining
for OPP incorporation was carried out as indicated by the manufacturer’s
instructions (Click-It OPP Flow Cytometry kit, Thermo Scientiﬁc) and the DNA
content was visualized with propidium iodide to distinguish between G0/G1 (DNA
content= 2c) and S/G2/M (DNA content > 2c). For analysis of protein synthesis
rates of Prom1+ cells, ﬁxed OPP-pulsed cells were stained for Prominin1 (rat
CD133 1:250, 14-1331-80 eBioscience; Dylight488 anti-rat 1:500, 112-486-072,
Thermo Scientiﬁc) in PBS+ 1% BSA (each for 30 min at 4 °C) before OPP Click-It
staining. The samples were analyzed on a BD FACS Canto II ﬂow cytometer.
FlowJo (Version 7.6.5) was used to process the obtained data. The relative rate of
protein translation was calculated by using the mean ﬂuorescent intensity relative
to control samples after subtraction of background staining and non-OPP-
incorporating dead cells. For each condition, cells from at least ﬁve embryos from
at least two different litters were measured (n ≥ 5).
Imaging, quantiﬁcation and statistical analysis. Epiﬂuorescence and confocal
micrographs were taken with a Leica DMI6000 B or a CLSM Leica SP8 upright
microscope, processed with Adobe Photoshop or Imaris and quantiﬁed manually
using ImageJ. For each quantiﬁcation, at least three mutants and three controls from
at least two different litters, and at least three sections per animal at different rostro-
caudal levels were analyzed. A radial unit was deﬁned as a 100 µm-wide stripe
measured at the ventricular surface with perpendicular borders given by the direction
of RG cell ﬁbers. Numbers of pHH3-positive cells were counted along the whole VZ
length and normalized to 600 μm VZ length. Measurements of cortical thickness,
length, and width were done with ImageJ. No statistical methods were used to pre-
determine sample size. Animals were not randomized and researchers were not
blinded during experiments and for quantiﬁcations. Statistical analysis of all experi-
ments was performed in Microsoft Excel using unpaired, two-tailed Student’s t test, or
in GraphPad Prism using analysis of variance Tukey’s multiple comparison test for
comparing more than two groups. Statistical signiﬁcance cutoff threshold was set at
p < 0.05. Results are shown as mean ± standard deviation, except where indicated.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The sequencing data sets generated and analyzed during the current study are available
in the European Nucleotide Archive (https://www.ebi.ac.uk/ena) and are accessible
through the accession numbers PRJEB21545, PRJEB30271, and PRJEB21635. All relevant
data that support the ﬁndings of this study are available from the corresponding author
upon reasonable request. Source data for all ﬁgures are provided as a Source Data ﬁle.
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